Immunai (United States)

Anti-GD2 CAR-NKT cells in patients with relapsed or refractory neuroblastoma: an interim analysis

Andras Heczey, Amy N. Courtney, Antonino Montalbano et al. · Nature Medicine · 2020 · 254 citations

Interim Analysis, Cell Therapy, Medicine +5

Neurocognitive and hypokinetic movement disorder with features of parkinsonism after BCMA-targeting CAR-T cell therapy

Oliver Van Oekelen, Adolfo Aleman, Bhaskar Upadhyaya et al. · Nature Medicine · 2021 · 228 citations · Full text

Corticobasal Degeneration, Medicine, Parkinson Disease +10

Gut CD4+ T cell phenotypes are a continuum molded by microbes, not by TH archetypes

Evgeny Kiner, Elijah Willie, Brinda Vijaykumar et al. · Nature Immunology · 2021 · 177 citations · Full text

Mucosal Immunology, Th Archetypes, T-regulatory Cell +7

A genome-scale screen for synthetic drivers of T cell proliferation

Mateusz Legut, Zoran Gajic, Maria Guarino et al. · Nature · 2022 · 173 citations · Full text

Human Cell, Medicine, T-regulatory Cell +9

Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results

Andras Heczey, Xin Xu, Amy N. Courtney et al. · Nature Medicine · 2023 · 161 citations

Cell Therapy, Refractory Neuroblastoma, Medicine +7